CNS Stimulants and Nonstimulants

Core Concepts

How stimulants work: dopamine and norepinephrine

Stimulant drugs for ADHD fall into two broad chemical families — amphetamine-type and methylphenidate-type — and both raise synaptic levels of dopamine and norepinephrine. Amphetamine-type drugs increase release of these neurotransmitters; methylphenidate-type drugs mainly block their reuptake. The net effect is the same: more neurotransmitter remains in the synapse, strengthening the brain circuits for attention, focus, and impulse control — and, outside the brain, increasing sympathetic activity that raises heart rate and blood pressure.

Because the mechanism is "more neurotransmitter," effects are dose-related: lower doses improve focus and alertness; higher doses produce increasing stimulation, agitation, and cardiovascular strain. Formulations range from short- to long-acting, changing how smoothly the effect rises and falls — but the nurse's job is mechanism-based: expect cardiovascular effects, appetite suppression, insomnia, and possible overstimulation at higher effective doses.

The controlled-substance reality

CNS stimulants used for ADHD are Schedule II controlled substances — the same regulatory tier as morphine — because of high abuse and dependence potential. With regular use the brain adapts (tolerance develops), and abrupt discontinuation can cause fatigue, depression, and sleep changes. That physical adaptation is distinct from misuse or addiction (compulsive use despite harm) — but the classification exists because the drugs reward the brain, so they attract misuse and diversion.

Nursing implications: verify orders carefully (look-alike/sound-alike names), document administration accurately, teach secure storage and never sharing the medication, and screen for signs of misuse or diversion (missing doses, frequent "lost prescription" reports, requests for dose escalation). The nurse is a partner in stewardship, not a police officer — the goal is safe use by the person it was prescribed for.

The nonstimulant options

Nonstimulant ADHD medications treat the same condition without directly boosting dopamine the way stimulants do. The two main groups:

• Selective norepinephrine-reuptake inhibitors (prototype: atomoxetine): block norepinephrine reuptake, improving attention without the same euphoria or abuse potential. Trade-offs: the effect builds gradually over days to weeks (not "take it and focus now"), and it carries its own side effects, including potential blood-pressure and heart-rate effects and, in some people, nausea, sleepiness, or mood changes. Not a controlled substance.
• Alpha-2 adrenergic agonists (prototype class: extended-release forms of drugs like guanfacine and clonidine): act on receptors that regulate norepinephrine signaling. Because they decrease sympathetic outflow, they can lower blood pressure and heart rate and cause sedation — the opposite cardiovascular direction from stimulants.

The clinical point: "stimulant vs. nonstimulant" is a mechanism and risk-profile distinction, not a ranking. Choice depends on the person's symptoms, comorbidities, tolerability, and preferences, and is made by the provider with the patient and family.

Narcolepsy: the other indication

Narcolepsy is a sleep disorder in which the brain cannot properly regulate sleep-wake states, causing overwhelming daytime sleepiness and, in some forms, sudden loss of muscle tone (cataplexy). Stimulants promote wakefulness, addressing the disabling sleepiness rather than the underlying sleep architecture — a reminder that "stimulant" is a mechanism label; the therapeutic goal depends entirely on the condition.

Nursing care and patient teaching

• Cardiovascular monitoring: baseline pulse and blood pressure before starting; monitor with reassessments and report significant changes, palpitations, or chest discomfort. Significant cardiac history may influence drug choice — the prescriber evaluates this.
• Growth and nutrition in children: appetite suppression is common; monitor weight and height over time, encourage nutrient-dense meals when the child is hungriest, and report growth concerns.
• Sleep: stimulants can cause insomnia, especially with late-day dosing; teach good sleep hygiene and report persistent problems.
• Mental status and mood: watch for anxiety, agitation, irritability, or unusual behaviors; these may be dose-related or a reason to revisit the plan.
• Safe use: take exactly as prescribed; do not crush or alter long-acting forms unless the product's instructions allow (verify per product and orders); never share; store securely; report missed doses rather than doubling up.
• Abrupt discontinuation can cause fatigue, depression, and sleep changes — changes are coordinated with the provider.
• Scope note: what the nurse may initiate, monitor, or adjust depends on state regulations, facility policy, and prescriber orders; no doses or schedules are given here — verify against current references and the formulary.

Common Confusions